Related Experiment Video
Updated: Jun 22, 2026

Three-Dimensional Cell Culture Models to Investigate the Epithelial Barrier in Eosinophilic Esophagitis
Published on: May 10, 2024
Defining eosinophilic colitis in children: insights from a retrospective case series
Sam Behjati1, Matthias Zilbauer, Robert Heuschkel
1Department of Histopathology, Royal Free Hampstead NHS Trust, Royal Free and University College Medical School Pond Street, London, UK.
Insights
Eosinophilic colitis in children is poorly understood. This study found no link between marked colonic eosinophilia and symptoms, atopy, or clinical outcomes in children over one year old.
Area of Science:
- Pediatric Gastroenterology
- Immunology
- Histopathology
Background:
- Eosinophilic colitis is a poorly defined diagnosis in children over 12 months old.
- Characterizing colonic eosinophilia in this age group is crucial for understanding its clinicopathological significance.
Purpose of the Study:
- To characterize colonic eosinophilia in children older than 12 months.
- To determine if colonic eosinophilia represents a distinct clinicopathological condition in this population.
Main Methods:
- Retrospective review of 38 children with colonic eosinophilia and 10 controls.
- Quantitative morphometric analysis of eosinophil density in gastrointestinal biopsies.
- Comparison of clinical data, atopic history, inflammatory markers, and outcomes among groups.
Main Results:
- A decreasing colonic eosinophil gradient from cecum to rectum was observed.
- Abnormal total immunoglobulin E (IgE) levels showed a significant association with moderate/severe colonic eosinophilia (P=0.03).
- No significant differences in other patient characteristics or consistent relation between eosinophil density and symptom progression were found.
Conclusions:
- Marked colonic eosinophilia, defined as "eosinophilic colitis," was not associated with symptoms, atopy, inflammatory markers, or clinical outcome in children over 12 months.
- The findings suggest that "eosinophilic colitis" as defined may not be a distinct clinicopathological entity in this age group.
- Further research is needed to clarify the role and significance of colonic eosinophilia in older children.
Objectives:
Although it is a well-described syndrome in infants, eosinophilic colitis is a loosely defined and poorly understood diagnosis in older children. The aims of this case series were to characterise colonic eosinophilia in children and to determine whether it represents a distinct clinicopathological condition.
Methods:
We retrospectively reviewed symptomatic children older than 12 months with the principal diagnosis of colonic eosinophilia who presented between January 2000 and February 2007 (n = 38) and a further 10 children whose colonic biopsies were reported as histologically normal. The eosinophil density in all available gastrointestinal biopsies (n = 620) of these children was determined using a validated quantitative morphometric method. Patients were subdivided according to mean colonic eosinophil levels into 3 groups (marked, moderate, or minimal colonic eosinophilia). The following patient information was obtained and compared among patient groups: symptoms prompting endoscopy, atopic history, outcome, serum C-reactive protein and total immunoglobulin E (IgE) levels, erythrocyte sedimentation rate, blood eosinophil count, and endoscopic findings.
Results:
In all 3 patient groups, there was a colonic gradient of decreasing eosinophil density from caecum to rectum. Upper gastrointestinal tract biopsies did not exhibit eosinophilia. Although a significant association (P = 0.03) between abnormal total IgE levels and moderate or severe colonic eosinophilia was found, there was no significant difference (P > 0.05) in other patient characteristics. Furthermore, follow-up data did not show a consistent relation between eosinophil density and progression of symptoms.
Conclusions:
We find no association between "eosinophilic colitis," defined as a histologically demonstrated marked colonic eosinophilia, and symptoms, history of atopy, inflammatory markers, or clinical outcome.
Related Concept Videos
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease I: Introduction
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Inflammatory Bowel Disease IV: Clinical Manifestations
